Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Landiolol

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section

No original site article was mapped to this record. The available historical structured fields and official-source links are retained.

Historical first look: uses, mechanism, dosing context, and administration

Recovered v5.1 source content; historical, awaiting current review.

Id
landiolol
Source IDH51-26E6AC100ED2A6961BCCF45F
Generic name
Landiolol
Source IDH51-45475949D160A3A677AC0546
Class
Cardiovascular and vasoactive
Source IDH51-B2C14C19D45279BCEF85541C
Subclass
Ultra-short-acting beta-1 blocker
Source IDH51-E3F2A4AD83263C4B990458AA
Primary uses
  1. Short-term reduction of ventricular rate in supraventricular tachycardia including atrial fibrillation/flutter in adults
    Source IDH51-82DA5401F7AA77CEA893AE92
Mechanism
Selectively blocks beta-1 adrenergic receptors and reduces heart rate, AV conduction, and contractility.
Source IDH51-E3E5BA6CD5D1C1294779A97F
Mechanism level
drug_specific
Source IDH51-E2C55CBCF5BEEC328F97E12F
Basic dosing orientation
Adult infusion | Existing preparation record; use current package insert for indication-specific selection | One 280 mg vial | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | Existing continuous-infusion record | Dose per current label and hemodynamic status | Continuous infusion; titration-specific | Clinical-response dependent | Continuous IV infusion
Source IDH51-B67F357ECEEBD19BC7C05C25
Administration orientation
Use weight-based pump rate; mL/hour = target mcg/kg/min x weight kg / 93; Titrate to ventricular-rate target; 280 mg/50 mL (5.6 mg/mL); Dose per current label and hemodynamic status; Titrate to ventricular-rate target
Source IDH51-FD0ED9F6F2283DA7946596C9
Renal and population orientation
Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source IDH51-A2967BAC6408EF440E0A6E3D
Key safety orientation
  1. Severe bradycardia, heart block, hypotension, cardiogenic shock, and decompensated heart failure.
    Source IDH51-867F27EECFAF82BF12F31553
  2. Continuous ECG and blood-pressure monitoring are required.
    Source IDH51-D3C5E76E6E4EFFA13C91CF2B
Coverage path
structured_local_snapshot
Source IDH51-D224AC62DEC6DE5FD33ECDF1
Coverage path label
Structured GlobalRPh route snapshot
Source IDH51-0EE481ED4252D883AC88F24F
Review note
First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source IDH51-B2E6797BFCEB1C05EB6502DB
Search text
Landiolol Cardiovascular and vasoactive Ultra-short-acting beta-1 blocker Short-term reduction of ventricular rate in supraventricular tachycardia including atrial fibrillation/flutter in adults Selectively blocks beta-1 adrenergic receptors and reduces heart rate, AV conduction, and contractility. Adult infusion | Existing preparation record; use current package insert for indication-specific selection | One 280 mg vial | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | Existing continuous-infusion record | Dose per current label and hemodynamic status | Continuous infusion; titration-specific | Clinical-response dependent | Continuous IV infusion Use weight-based pump rate; mL/hour = target mcg/kg/min x weight kg / 93; Titrate to ventricular-rate target; 280 mg/50 mL (5.6 mg/mL); Dose per current label and hemodynamic status; Titrate to ventricular-rate target Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Severe bradycardia, heart block, hypotension, cardiogenic shock, and decompensated heart failure. Continuous ECG and blood-pressure monitoring are required. Structured GlobalRPh route snapshot
Source IDH51-EC652A9DC0D26BF3FD7FD036
Official access mode
direct_label
Source IDH51-A03032387AFBCF73A9A3F211
Official access reason
A source-specific DailyMed label route is available.
Source IDH51-AF25259793A6E0C4DDE946FB
Label snapshot available
true
Source IDH51-B77CD7DB3F2AC769E5B27A80
Label snapshot setid
27e7f20f-78a4-f1a9-e063-6394a90ae465
Source IDH51-1A610B7C1D7643222D194A8A
Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • A retrieved source document is available; clinical reconciliation and a second-source claim map remain incomplete
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
current_label_review_required
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      • Source kind
        label_snapshot
        Local pointer
        /mechanism_summary
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.

      No separate structured rows were bundled for IV push, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical dilution and intermittent infusion preparation

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationAmountReconstitutionDiluentFinal volumeConcentrationRateStabilityNotes
      Source IDH51-01E6B5647B1448C7832E36A1
      Adult infusion
      Source IDH51-277E4465D49851A210E7EC48
      One 280 mg vial
      Source IDH51-DE96D1A9F60358237134C5D1
      Reconstitute with 50 mL NS or D5W and gently swirl.
      Source IDH51-9AE26B1E3E80C40B6E64CE74
      NS or D5W used for reconstitution
      Source IDH51-4CC914441761417E4DCFB365
      50 mL
      Source IDH51-F4AD8E2DDE008F77A8CE5EAC
      5.6 mg/mL
      Source IDH51-3190CBA7240E4D5F14B4AD6E
      Use weight-based pump rate; mL/hour = target mcg/kg/min x weight kg / 93
      Source IDH51-CCF6AE4C4C9DFF808B2D8A90
      NS preparation: use within 4 hours at room temperature. D5W preparation: use within 48 hours at room temperature.
      Source IDH51-D14E613BDE21B14A5F95A7AD
      Use immediately when possible and discard unused portion.
      Source IDH51-E759348E6BBF0B644F6BA473

      Historical DailyMed label snapshot

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      landiolol
      Source IDH51-F42AD5ED7F34CD0FE9270538
      Catalog name
      Landiolol
      Source IDH51-AD4BEDAD6DC1C520131B2887
      Selection status
      accepted_high_confidence
      Source IDH51-9BA4A38C30438C20E56D09D9
      Confidence
      very_high
      Source IDH51-84FE1E9BD88AFD5D184C3299
      Match path
      verified_direct_label
      Source IDH51-D1948C6693F10AA85B7491DE
      Brand name
      RAPIBLYK
      Source IDH51-38F67450FC222A4C5724423A
      Label title
      RAPIBLYK (landiolol) injection, powder, lyophilized, for solution
      Source IDH51-EADCE55FC7B5F25A3C5BC511
      Setid
      27e7f20f-78a4-f1a9-e063-6394a90ae465
      Source IDH51-7FB482BF1AB249EA4872CBD8
      Route
      Titrated continuous intravenous infusion
      Source IDH51-22FBC480435DC903759C4953
      Dosage form
      Lyophilized powder for reconstitution
      Source IDH51-8FC47FA3A369CE310A177EAF
      Dosage administration summary
      1. Administer as a continuous intravenous infusion in a monitored setting and titrate to ventricular-rate response.
        Source IDH51-3C763D0DB6F673CCF9C7941C
      2. With normal cardiac function, the current label starts at 9 mcg/kg/min and permits 9 mcg/kg/min increases at 10-minute intervals to 36 mcg/kg/min. With impaired cardiac function, use the lower 1 mcg/kg/min starting and titration steps.
        Source IDH51-C8E94E640AFAA099E187DE11
      3. Reconstitute the 280 mg vial with 50 mL of 0.9% sodium chloride or 5% dextrose to 5.6 mg/mL and follow the diluent-specific in-use limits.
        Source IDH51-B7C8FD77CEBA18CB972BAE90
      Dosage forms strengths
      1. 280 mg landiolol, equivalent to 300 mg landiolol hydrochloride, in a single-dose vial
        Source IDH51-89AD32F1109DFAA458E30E24
      Mechanism summary
      Landiolol is an ultra-short-acting, beta1-selective adrenergic-receptor blocker that reduces heart rate and atrioventricular conduction.
      Source IDH51-3D05A5E03DF2CC05BCDE5677
      Scope note
      Selected RAPIBLYK label. Continuous rhythm, heart-rate, blood-pressure, and heart-failure monitoring are required.
      Source IDH51-BE497617F7DCEF621F52C8A6
      Reviewed on
      2026-08-31
      Source IDH51-890F4F074364225AEC8948B6
      Mechanism source
      Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
      Source IDH51-4470C29623EF06D32A1827C6
      Source sections
      1. Dosage and Administration
        Source IDH51-FE7E9CA7961C0EEC43FFE6B6
      2. Dosage Forms and Strengths
        Source IDH51-2AEB7D9539DD8B0DD0884A4C
      3. Clinical Pharmacology or Microbiology as applicable
        Source IDH51-1FA6A27316AE9B779E9553C9
      Retrieval method
      Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
      Source IDH51-DFD5CE3F58DC7EC1A439A776
      Label status
      current
      Source IDH51-41C606FB0C9686EBB6C1F658
      Disclaimer
      Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
      Source IDH51-BAFBBAEEFC76D8E387A1F08A

      Historical continuous-infusion guidance

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationStandard concentrationInitial rateTitrationMaximumNotes
      Source IDH51-2001D46D54937DB624F01FE5
      Adult
      Source IDH51-4673DF0D4131E34B20372D36
      280 mg/50 mL (5.6 mg/mL)
      Source IDH51-A0F535BD92C5EED652EB0225
      Dose per current label and hemodynamic status
      Source IDH51-21E4F3D9B6487B529FCB11E1
      Titrate to ventricular-rate target
      Source IDH51-D22DF6E6D05E36D3905DDFF9
      Current label maximum
      Source IDH51-6712119276ECF7C9EBE25E8F
      Transition to oral beta blocker using the label-directed overlap and taper method.
      Source IDH51-B55C3020E3B88A5FE1336FC2

      Historical indication and population dosing

      Recovered tables and source-separated snapshots; full clinical revalidation remains pending.

      Existing dose and route snapshots

      RoutePopulationIndicationDoseIntervalDurationAdministrationSource levelNotes
      Source IDH51-628F428EBC6D2724CC468810
      IV infusion
      Source IDH51-DC9B7ACDD235A1397653ECC8
      Adult infusion
      Source IDH51-863AD2B4D77F7653B1BD81D2
      Existing preparation record; use current package insert for indication-specific selection
      Source IDH51-A82016A094542C59B5C21B0D
      One 280 mg vial
      Source IDH51-497E64AD92F203EB98675F11
      Not normalized in the preparation record
      Source IDH51-03411431FADB35BB0203EA4D
      See current package insert and professional guidance
      Source IDH51-F7ED00E1397EE1F9F0DDF016
      Use weight-based pump rate; mL/hour = target mcg/kg/min x weight kg / 93
      Source IDH51-7A6ECC44FAD436FC0D69BDFF
      Existing GlobalRPh structured preparation snapshot
      Source IDH51-1E8A8475C5C4F768347C9908
      Use immediately when possible and discard unused portion.
      Source IDH51-08BDDA0E576D08A61CE5285C
      Source IDH51-55F4EBF0D3E6025DA6D41852
      Continuous IV infusion
      Source IDH51-95DA27C07A2C7F31085D66B9
      Adult
      Source IDH51-3A3A93620465B76ADFC93777
      Existing continuous-infusion record
      Source IDH51-A75BC2E41494AE66DB21355A
      Dose per current label and hemodynamic status
      Source IDH51-F772363F12A5A46B2C4F15EC
      Continuous infusion; titration-specific
      Source IDH51-DCBBB023B6C9541EBCFFE65D
      Clinical-response dependent
      Source IDH51-642FBEAD772C25E3AF340117
      Titrate to ventricular-rate target
      Source IDH51-A15B6579A5D70673DFA45368
      Existing GlobalRPh continuous-infusion snapshot
      Source IDH51-4C9A977113C8E10BA028A3F8
      Current label maximum Transition to oral beta blocker using the label-directed overlap and taper method.
      Source IDH51-517234BE783343F50E74A1DB

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      current_label_review_required
      Source IDH51-F1A260D4049AE78A5E853369
      Summary
      Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
      Source IDH51-D08E0656853B6786A11F6C58
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-E1A516B91DF2ED25C9293BD2

      Historical Common IV uses

      Recovered v5.1 source content; historical, awaiting current review.

      1. Short-term reduction of ventricular rate in supraventricular tachycardia including atrial fibrillation/flutter in adults
        Source IDH51-120524BBFAB46277F9A0F9F4

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      1. Severe bradycardia, heart block, hypotension, cardiogenic shock, and decompensated heart failure.
        Source IDH51-D1F116741CCDF1A3B719F635
      2. Continuous ECG and blood-pressure monitoring are required.
        Source IDH51-756549D12EB4E62556D2B9A1

      Historical Monitoring

      Recovered v5.1 source content; historical, awaiting current review.

      1. Continuous ECG
        Source IDH51-98DC7836E07B4D494399367A
      2. Blood pressure
        Source IDH51-49DF8363E08D864D84C6D1C5
      3. Signs of heart failure and bronchospasm
        Source IDH51-92EBE4E7DC6EA789D27B275A
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      landiolol
      Source IDH51-9C7071B30663C08A787799E2
      Generic name
      Landiolol
      Source IDH51-D373976861897BE2EA89A720
      Brand names
      1. Rapiblyk
        Source IDH51-5F83A42F2B3CF887AE87191C
      Class
      Cardiovascular and vasoactive
      Source IDH51-BBB1533D282F287D8A48AFB3
      Subclass
      Ultra-short-acting beta-1 blocker
      Source IDH51-559AE7F53BC67DDE92E0EA86
      Summary
      Ultra-short-acting beta-1 blocker supplied as a 280 mg lyophilized vial and prepared at 5.6 mg/mL for continuous infusion.
      Source IDH51-4D01A4C9D6114A39BD5E480C
      Populations
      1. Adult
        Source IDH51-2ED22F557A97EBD3F16E188E
      Evidence tier
      Current-label candidate - verify exact product
      Source IDH51-6C83BE2ED5D664AC7485CF60
      High alert
      false
      Source IDH51-EFA41EA394DDD8B51C581FD3
      Hazardous
      false
      Source IDH51-5706B176A448DDF0A69423C4
      Status
      Active
      Source IDH51-03CBB4484E33A285BB1286B4
      Reviewed
      2026-08-29
      Source IDH51-3E09D08515FFA8B4895B7BE8
      Version added
      1.2
      Source IDH51-8066390A2FB20FC3D7524C6E
      Sources
      LabelUrlKind
      Source IDH51-DC407EE46185487DC7E4CF32
      DailyMed RAPIBLYK prescribing information
      Source IDH51-C152B0CF9D5A6EE94AD9CC61
      https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27e7f20f-78a4-f1a9-e063-6394a90ae465 (opens in a new tab)
      Source IDH51-DF261130101A188C7CFFF3E7
      Primary
      Source IDH51-B76E79980F8AC69F063B864B
      Source IDH51-A86CEC62766676E58DD7DA6D
      GlobalRPh legacy IV dilution monograph
      Source IDH51-83F119AC7919983879500C88
      legacy:auto
      Source IDH51-D32B255AEF37E97F46DE42BB
      Legacy
      Source IDH51-FDDFD39D02337BE999AC94FC
      Clinical release verification
      Audit version
      3.4
      Source IDH51-261F3BB14177DD3583AC7900
      Audited on
      2026-08-30
      Source IDH51-4C8D2B6DB445A320ED61653C
      Level
      amber
      Source IDH51-791332A5B03DAE7BA6C8D85A
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-E12665AFACCA01B699FE5AA7
      Exact current label candidate
      false
      Source IDH51-B2D00B3861956F8BB0423A3D
      Selected setid
      27e7f20f-78a4-f1a9-e063-6394a90ae465
      Source IDH51-03FCEEE209B770A9D33AD821
      Numeric support ratio
      0
      Source IDH51-DA5D16870E3D3EE961CEC09D
      Reference url count
      1
      Source IDH51-560A7D6A06813129DF42F634
      Broken reference count
      0
      Source IDH51-FB1AA9AE93B9B2BE79872983
      Point of use confirmation required
      true
      Source IDH51-95B96B6214DE7FD8F0B58E1E
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-ADE106CAA3B71DE69A115232

      Dosing source fields

      Id
      landiolol
      Source IDH51-76369F3CA4F5F868DE961ACE
      Generic name
      Landiolol
      Source IDH51-F84A87C9E73D94837E8BFE95
      Coverage status
      direct_official_label_access_plus_local_snapshot
      Source IDH51-66C769FBF2C9EC5847273F8C
      Package insert
      Query name
      Landiolol
      Source IDH51-79AA5F65CF6E41D771079FF9
      Preferred setid
      27e7f20f-78a4-f1a9-e063-6394a90ae465
      Source IDH51-11F0E17DF91A3182C8D8A16E
      Product and route must match
      true
      Source IDH51-EDACB9E1177061E341709FCC
      Live current label enabled
      false
      Source IDH51-B1992515BC4098A46D9AB3C2
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-3E0688731FBE838D5CDA4DFA
      Direct official label access enabled
      true
      Source IDH51-3AE1A262F709E627CF5F3F1E
      Outbound server request required
      false
      Source IDH51-87B81928FB4562358529E88B
      Local summary status
      not_bundled
      Source IDH51-7BB58A17E42C993DAF8EF18B
      Clinical review
      Locally normalized
      false
      Source IDH51-9A926535811BEB8C377A06FF
      Reviewed
      2026-08-29
      Source IDH51-913D431D736D8BDF084E911A
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-4F42E4891E3C1FE5CEBE4C17
      Clinical release verification
      Audit version
      3.4
      Source IDH51-DA808AD3F2774F93BBCB1158
      Audited on
      2026-08-30
      Source IDH51-D0A349D22030F41BEE623B07
      Level
      amber
      Source IDH51-E41630322B435092FB2CF260
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-7A096CD1E1A0B0A2F775C3FC
      Exact current label candidate
      false
      Source IDH51-A434CB6D9F44327FFBF3C54A
      Selected setid
      27e7f20f-78a4-f1a9-e063-6394a90ae465
      Source IDH51-3878BFE4E31D6DD7B216BCEF
      Numeric support ratio
      0
      Source IDH51-4433D83D0C6B904D0CD7945F
      Reference url count
      1
      Source IDH51-DED4036BD00D67B7E08B1519
      Broken reference count
      0
      Source IDH51-EC0867137471AF75B580A3C5
      Point of use confirmation required
      true
      Source IDH51-FFE40DA7ACCEF29A933FCA75
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-7BEF4670A5BA751416B62179
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      landiolol
      Source IDH51-BCA92F09C915AB9D3630D9B0
      Name
      Landiolol
      Source IDH51-192DC07FE3906E1C14374578
      Brands
      Rapiblyk
      Source IDH51-6703F109D7376B6DB42F805C
      Therapeutic class
      Cardiovascular and vasoactive
      Source IDH51-0D934D7E2AA5467F3EEB41A5
      Review version
      3.1
      Source IDH51-B64622538EB3B563ADF00582
      Review date
      2026-08-30
      Source IDH51-02DA0C304B4E1B9DB67BFE53
      Release status
      structured_record_current_label_not_confirmed
      Source IDH51-3AEFFD95A13DD9436970D8D1
      Market status
      Status
      no_current_us_iv_spl_confirmed
      Source IDH51-D62E299FD99A797C30672E3D
      Basis
      No high-confidence current IV SPL was automatically selected; legacy information is segregated
      Source IDH51-04DF267985B15CE68962A131
      Ten point assessment
      Exact formulation
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-1068DF5B4348CADC6B69C01D
      Reconstitution concentration
      Reconstitute with 50 mL NS or D5W and gently swirl.
      Source IDH51-33399054EC4543C783024B20
      Maximum or recommended final concentration
      280 mg/50 mL (5.6 mg/mL)
      Source IDH51-CEF6F90AA8A2A3C55DC14C33
      Appropriate standardized containers
      50 mL
      Source IDH51-53FBCDD0DEFFE4417C34D244
      Adult dosing range
      One 280 mg vial Dose per current label and hemodynamic status
      Source IDH51-98A424C8D3F4B2DB2901B82C
      Pediatric dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-51EB610E4325194ABBC9984E
      Neonatal dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-02B342AF584844F26B8042B8
      Infusion time
      Use weight-based pump rate; mL/hour = target mcg/kg/min x weight kg / 93 Dose per current label and hemodynamic status
      Source IDH51-46E0169269B555E4D76F2D07
      Fluid restriction alternatives
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-6D01025B76B84E31A1A2A6BE
      Current manufacturer labeling
      Setid
      27e7f20f-78a4-f1a9-e063-6394a90ae465
      Source IDH51-5F5727DA1498FDB0C00C2311
      Match confidence
      unresolved
      Source IDH51-BBF130FADE3305570512A0E3
      Field provenance
      Exact formulation
      Primary
      not_found
      Source IDH51-9A09CA7B23FF9260A680DC17
      Reconstitution concentration
      Primary
      existing_structured_record
      Source IDH51-DE12C105DF1021A855A2D2FC
      Maximum or recommended final concentration
      Primary
      existing_structured_record
      Source IDH51-D40CD1EB72A2760F3FFFA3B4
      Appropriate standardized containers
      Primary
      existing_structured_record
      Source IDH51-D5D7D3F73F40320CE64690D6
      Adult dosing range
      Primary
      existing_structured_record
      Source IDH51-AD5E30E35193FC3B9BDA517B
      Pediatric dosing range
      Primary
      not_found
      Source IDH51-18FDE8895009589CB1E78021
      Neonatal dosing range
      Primary
      not_found
      Source IDH51-E5305CA7A105772BFD686C4B
      Infusion time
      Primary
      existing_structured_record
      Source IDH51-50EBD0CC6AF279C862C70E53
      Fluid restriction alternatives
      Primary
      not_found
      Source IDH51-6DCEA7FD1303D8C2B037C3A9
      Current manufacturer labeling
      Primary
      DailyMed current-label gateway
      Source IDH51-A093CEE43C023B27685E40AC
      Population applicability
      Adult
      Applicability
      supported_or_source_present
      Source IDH51-FEED401D04F749FFF126F307
      Guide generation allowed
      true
      Source IDH51-9E1D8EA051744A02D2C17C20
      Pediatric
      Applicability
      not_established
      Source IDH51-6596683324DFAE11678CD41F
      Guide generation allowed
      false
      Source IDH51-6C6FDB761E7E5D6C782D6F0B
      Neonatal
      Applicability
      not_established
      Source IDH51-F2E06C99FE9E9B11993CA919
      Guide generation allowed
      false
      Source IDH51-47B35A298120B9618EBD791A
      Route presence
      Structured dilution
      true
      Source IDH51-A8E82FB3AC12638F172829DA
      Iv push
      false
      Source IDH51-5E380301450D86A1E414BFC2
      Continuous infusion
      true
      Source IDH51-9715DDA077012B9A6F087D2D
      Pediatric source
      false
      Source IDH51-B7F1B8499812B41A9D6B8221
      Neonatal source
      false
      Source IDH51-294118602529701A8A1E7F9B
      Legacy reference
      Status
      not_available
      Source IDH51-0BF915FF33D5C7C72B6E9082
      Label resolution
      Status
      build_environment_network_unavailable
      Source IDH51-882936034BBE320BBAEBBBA1
      Existing setids
      1. 27e7f20f-78a4-f1a9-e063-6394a90ae465
        Source IDH51-94C078ECD8B054E78F80F558
      Concentration values detected
      HighUnitText
      Source IDH51-7724139FDA90BBE662356A94
      5.6
      Source IDH51-4AC9C6B9D01D60B92ACEEB68
      mg
      Source IDH51-E513254F3EFB8999B17F95A8
      5.6 mg/mL
      Source IDH51-60508C0EBF44AB06EEEBEE3C
      Source files
      1. catalog.json
        Source IDH51-4B05123F41A0E2A1FAED3EE1
      2. dosing.json
        Source IDH51-58A0A1364EC9425C320A2CDE
      3. new-in-v1.2.json
        Source IDH51-BB24117F01AB73A38981CCE4
      Clinical release note
      Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
      Source IDH51-B558E50D9F565EBE80806400
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-9C7071B30663C08A787799E2catalog.json
      /records/144/id
      Historical; current review incomplete
      H51-D373976861897BE2EA89A720catalog.json
      /records/144/generic_name
      Historical; current review incomplete
      H51-5F83A42F2B3CF887AE87191Ccatalog.json
      /records/144/brand_names/0
      Historical; current review incomplete
      H51-BBB1533D282F287D8A48AFB3catalog.json
      /records/144/class
      Historical; current review incomplete
      H51-559AE7F53BC67DDE92E0EA86catalog.json
      /records/144/subclass
      Historical; current review incomplete
      H51-4D01A4C9D6114A39BD5E480Ccatalog.json
      /records/144/summary
      Historical; current review incomplete
      H51-120524BBFAB46277F9A0F9F4catalog.json
      /records/144/common_uses/0
      Historical; current review incomplete
      H51-01E6B5647B1448C7832E36A1catalog.json
      /records/144/preparations/0
      Historical; current review incomplete
      H51-277E4465D49851A210E7EC48catalog.json
      /records/144/preparations/0/population
      Historical; current review incomplete
      H51-DE96D1A9F60358237134C5D1catalog.json
      /records/144/preparations/0/amount
      Historical; current review incomplete
      H51-9AE26B1E3E80C40B6E64CE74catalog.json
      /records/144/preparations/0/reconstitution
      Historical; current review incomplete
      H51-4CC914441761417E4DCFB365catalog.json
      /records/144/preparations/0/diluent
      Historical; current review incomplete
      H51-F4AD8E2DDE008F77A8CE5EACcatalog.json
      /records/144/preparations/0/final_volume
      Historical; current review incomplete
      H51-3190CBA7240E4D5F14B4AD6Ecatalog.json
      /records/144/preparations/0/concentration
      Historical; current review incomplete
      H51-CCF6AE4C4C9DFF808B2D8A90catalog.json
      /records/144/preparations/0/rate
      Historical; current review incomplete
      H51-D14E613BDE21B14A5F95A7ADcatalog.json
      /records/144/preparations/0/stability
      Historical; current review incomplete
      H51-E759348E6BBF0B644F6BA473catalog.json
      /records/144/preparations/0/notes
      Historical; current review incomplete
      H51-2001D46D54937DB624F01FE5catalog.json
      /records/144/continuous_infusions/0
      Historical; current review incomplete
      H51-4673DF0D4131E34B20372D36catalog.json
      /records/144/continuous_infusions/0/population
      Historical; current review incomplete
      H51-A0F535BD92C5EED652EB0225catalog.json
      /records/144/continuous_infusions/0/standard_concentration
      Historical; current review incomplete
      H51-21E4F3D9B6487B529FCB11E1catalog.json
      /records/144/continuous_infusions/0/initial_rate
      Historical; current review incomplete
      H51-D22DF6E6D05E36D3905DDFF9catalog.json
      /records/144/continuous_infusions/0/titration
      Historical; current review incomplete
      H51-6712119276ECF7C9EBE25E8Fcatalog.json
      /records/144/continuous_infusions/0/maximum
      Historical; current review incomplete
      H51-B55C3020E3B88A5FE1336FC2catalog.json
      /records/144/continuous_infusions/0/notes
      Historical; current review incomplete
      H51-D1F116741CCDF1A3B719F635catalog.json
      /records/144/warnings/0
      Historical; current review incomplete
      H51-756549D12EB4E62556D2B9A1catalog.json
      /records/144/warnings/1
      Historical; current review incomplete
      H51-98DC7836E07B4D494399367Acatalog.json
      /records/144/monitoring/0
      Historical; current review incomplete
      H51-49DF8363E08D864D84C6D1C5catalog.json
      /records/144/monitoring/1
      Historical; current review incomplete
      H51-92EBE4E7DC6EA789D27B275Acatalog.json
      /records/144/monitoring/2
      Historical; current review incomplete
      H51-2ED22F557A97EBD3F16E188Ecatalog.json
      /records/144/populations/0
      Historical; current review incomplete
      H51-6C83BE2ED5D664AC7485CF60catalog.json
      /records/144/evidence_tier
      Historical; current review incomplete
      H51-EFA41EA394DDD8B51C581FD3catalog.json
      /records/144/high_alert
      Historical; current review incomplete
      H51-5706B176A448DDF0A69423C4catalog.json
      /records/144/hazardous
      Historical; current review incomplete
      H51-03CBB4484E33A285BB1286B4catalog.json
      /records/144/status
      Historical; current review incomplete
      H51-3E09D08515FFA8B4895B7BE8catalog.json
      /records/144/reviewed
      Historical; current review incomplete
      H51-8066390A2FB20FC3D7524C6Ecatalog.json
      /records/144/version_added
      Historical; current review incomplete
      H51-DC407EE46185487DC7E4CF32catalog.json
      /records/144/sources/0
      Historical; current review incomplete
      H51-C152B0CF9D5A6EE94AD9CC61catalog.json
      /records/144/sources/0/label
      Historical; current review incomplete
      H51-DF261130101A188C7CFFF3E7catalog.json
      /records/144/sources/0/url
      Historical; current review incomplete
      H51-B76E79980F8AC69F063B864Bcatalog.json
      /records/144/sources/0/kind
      Historical; current review incomplete
      H51-A86CEC62766676E58DD7DA6Dcatalog.json
      /records/144/sources/1
      Historical; current review incomplete
      H51-83F119AC7919983879500C88catalog.json
      /records/144/sources/1/label
      Historical; current review incomplete
      H51-D32B255AEF37E97F46DE42BBcatalog.json
      /records/144/sources/1/url
      Historical; current review incomplete
      H51-FDDFD39D02337BE999AC94FCcatalog.json
      /records/144/sources/1/kind
      Historical; current review incomplete
      H51-F0B843D035FF78A79C04298Ecatalog.json
      /records/144/legacy_title
      Historical; current review incomplete
      H51-261F3BB14177DD3583AC7900catalog.json
      /records/144/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-4C8D2B6DB445A320ED61653Ccatalog.json
      /records/144/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-791332A5B03DAE7BA6C8D85Acatalog.json
      /records/144/clinical_release_verification/level
      Historical; current review incomplete
      H51-E12665AFACCA01B699FE5AA7catalog.json
      /records/144/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-B2D00B3861956F8BB0423A3Dcatalog.json
      /records/144/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-03FCEEE209B770A9D33AD821catalog.json
      /records/144/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-67F67401F60F45AD10108BE7catalog.json
      /records/144/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-DA5D16870E3D3EE961CEC09Dcatalog.json
      /records/144/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-560A7D6A06813129DF42F634catalog.json
      /records/144/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-FB1AA9AE93B9B2BE79872983catalog.json
      /records/144/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-95B96B6214DE7FD8F0B58E1Ecatalog.json
      /records/144/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-ADE106CAA3B71DE69A115232catalog.json
      /records/144/clinical_release_verification/note
      Historical; current review incomplete
      H51-5DCF5FCF8DF9A9FBFAB3A936catalog.json
      /records/144/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-F42AD5ED7F34CD0FE9270538dailymed-label-snapshots-v5.1.json
      /records/36/id
      Historical; current review incomplete
      H51-AD4BEDAD6DC1C520131B2887dailymed-label-snapshots-v5.1.json
      /records/36/catalog_name
      Historical; current review incomplete
      H51-9BA4A38C30438C20E56D09D9dailymed-label-snapshots-v5.1.json
      /records/36/selection_status
      Historical; current review incomplete
      H51-84FE1E9BD88AFD5D184C3299dailymed-label-snapshots-v5.1.json
      /records/36/confidence
      Historical; current review incomplete
      H51-D1948C6693F10AA85B7491DEdailymed-label-snapshots-v5.1.json
      /records/36/match_path
      Historical; current review incomplete
      H51-38F67450FC222A4C5724423Adailymed-label-snapshots-v5.1.json
      /records/36/brand_name
      Historical; current review incomplete
      H51-EADCE55FC7B5F25A3C5BC511dailymed-label-snapshots-v5.1.json
      /records/36/label_title
      Historical; current review incomplete
      H51-7FB482BF1AB249EA4872CBD8dailymed-label-snapshots-v5.1.json
      /records/36/setid
      Historical; current review incomplete
      H51-22FBC480435DC903759C4953dailymed-label-snapshots-v5.1.json
      /records/36/route
      Historical; current review incomplete
      H51-8FC47FA3A369CE310A177EAFdailymed-label-snapshots-v5.1.json
      /records/36/dosage_form
      Historical; current review incomplete
      H51-3C763D0DB6F673CCF9C7941Cdailymed-label-snapshots-v5.1.json
      /records/36/dosage_administration_summary/0
      Historical; current review incomplete
      H51-C8E94E640AFAA099E187DE11dailymed-label-snapshots-v5.1.json
      /records/36/dosage_administration_summary/1
      Historical; current review incomplete
      H51-B7C8FD77CEBA18CB972BAE90dailymed-label-snapshots-v5.1.json
      /records/36/dosage_administration_summary/2
      Historical; current review incomplete
      H51-89AD32F1109DFAA458E30E24dailymed-label-snapshots-v5.1.json
      /records/36/dosage_forms_strengths/0
      Historical; current review incomplete
      H51-3D05A5E03DF2CC05BCDE5677dailymed-label-snapshots-v5.1.json
      /records/36/mechanism_summary
      Historical; current review incomplete
      H51-BE497617F7DCEF621F52C8A6dailymed-label-snapshots-v5.1.json
      /records/36/scope_note
      Historical; current review incomplete
      H51-360CA3083EE527D23AC0C0ECdailymed-label-snapshots-v5.1.json
      /records/36/labeler
      Historical; current review incomplete
      H51-F5FA172B5FB25EE9DA26B357dailymed-label-snapshots-v5.1.json
      /records/36/official_label_url
      Historical; current review incomplete
      H51-890F4F074364225AEC8948B6dailymed-label-snapshots-v5.1.json
      /records/36/reviewed_on
      Historical; current review incomplete
      H51-4470C29623EF06D32A1827C6dailymed-label-snapshots-v5.1.json
      /records/36/mechanism_source
      Historical; current review incomplete
      H51-FE7E9CA7961C0EEC43FFE6B6dailymed-label-snapshots-v5.1.json
      /records/36/source_sections/0
      Historical; current review incomplete
      H51-2AEB7D9539DD8B0DD0884A4Cdailymed-label-snapshots-v5.1.json
      /records/36/source_sections/1
      Historical; current review incomplete
      H51-1FA6A27316AE9B779E9553C9dailymed-label-snapshots-v5.1.json
      /records/36/source_sections/2
      Historical; current review incomplete
      H51-DFD5CE3F58DC7EC1A439A776dailymed-label-snapshots-v5.1.json
      /records/36/retrieval_method
      Historical; current review incomplete
      H51-41C606FB0C9686EBB6C1F658dailymed-label-snapshots-v5.1.json
      /records/36/label_status
      Historical; current review incomplete
      H51-BAFBBAEEFC76D8E387A1F08Adailymed-label-snapshots-v5.1.json
      /records/36/disclaimer
      Historical; current review incomplete
      H51-76369F3CA4F5F868DE961ACEdosing.json
      /records/144/id
      Historical; current review incomplete
      H51-F84A87C9E73D94837E8BFE95dosing.json
      /records/144/generic_name
      Historical; current review incomplete
      H51-66C769FBF2C9EC5847273F8Cdosing.json
      /records/144/coverage_status
      Historical; current review incomplete
      H51-79AA5F65CF6E41D771079FF9dosing.json
      /records/144/package_insert/query_name
      Historical; current review incomplete
      H51-11F0E17DF91A3182C8D8A16Edosing.json
      /records/144/package_insert/preferred_setid
      Historical; current review incomplete
      H51-EDACB9E1177061E341709FCCdosing.json
      /records/144/package_insert/product_and_route_must_match
      Historical; current review incomplete
      H51-B1992515BC4098A46D9AB3C2dosing.json
      /records/144/package_insert/live_current_label_enabled
      Historical; current review incomplete
      H51-3E0688731FBE838D5CDA4DFAdosing.json
      /records/144/package_insert/source_priority
      Historical; current review incomplete
      H51-3AE1A262F709E627CF5F3F1Edosing.json
      /records/144/package_insert/direct_official_label_access_enabled
      Historical; current review incomplete
      H51-87B81928FB4562358529E88Bdosing.json
      /records/144/package_insert/outbound_server_request_required
      Historical; current review incomplete
      H51-7BB58A17E42C993DAF8EF18Bdosing.json
      /records/144/package_insert/local_summary_status
      Historical; current review incomplete
      H51-F1A260D4049AE78A5E853369dosing.json
      /records/144/renal/classification
      Historical; current review incomplete
      H51-D08E0656853B6786A11F6C58dosing.json
      /records/144/renal/summary
      Historical; current review incomplete
      H51-E1A516B91DF2ED25C9293BD2dosing.json
      /records/144/renal/method_note
      Historical; current review incomplete
      H51-628F428EBC6D2724CC468810dosing.json
      /records/144/existing_route_snapshots/0
      Historical; current review incomplete
      H51-DC9B7ACDD235A1397653ECC8dosing.json
      /records/144/existing_route_snapshots/0/route
      Historical; current review incomplete
      H51-863AD2B4D77F7653B1BD81D2dosing.json
      /records/144/existing_route_snapshots/0/population
      Historical; current review incomplete
      H51-A82016A094542C59B5C21B0Ddosing.json
      /records/144/existing_route_snapshots/0/indication
      Historical; current review incomplete
      H51-497E64AD92F203EB98675F11dosing.json
      /records/144/existing_route_snapshots/0/dose
      Historical; current review incomplete
      H51-03411431FADB35BB0203EA4Ddosing.json
      /records/144/existing_route_snapshots/0/interval
      Historical; current review incomplete
      H51-F7ED00E1397EE1F9F0DDF016dosing.json
      /records/144/existing_route_snapshots/0/duration
      Historical; current review incomplete
      H51-7A6ECC44FAD436FC0D69BDFFdosing.json
      /records/144/existing_route_snapshots/0/administration
      Historical; current review incomplete
      H51-1E8A8475C5C4F768347C9908dosing.json
      /records/144/existing_route_snapshots/0/source_level
      Historical; current review incomplete
      H51-08BDDA0E576D08A61CE5285Cdosing.json
      /records/144/existing_route_snapshots/0/notes
      Historical; current review incomplete
      H51-55F4EBF0D3E6025DA6D41852dosing.json
      /records/144/existing_route_snapshots/1
      Historical; current review incomplete
      H51-95DA27C07A2C7F31085D66B9dosing.json
      /records/144/existing_route_snapshots/1/route
      Historical; current review incomplete
      H51-3A3A93620465B76ADFC93777dosing.json
      /records/144/existing_route_snapshots/1/population
      Historical; current review incomplete
      H51-A75BC2E41494AE66DB21355Adosing.json
      /records/144/existing_route_snapshots/1/indication
      Historical; current review incomplete
      H51-F772363F12A5A46B2C4F15ECdosing.json
      /records/144/existing_route_snapshots/1/dose
      Historical; current review incomplete
      H51-DCBBB023B6C9541EBCFFE65Ddosing.json
      /records/144/existing_route_snapshots/1/interval
      Historical; current review incomplete
      H51-642FBEAD772C25E3AF340117dosing.json
      /records/144/existing_route_snapshots/1/duration
      Historical; current review incomplete
      H51-A15B6579A5D70673DFA45368dosing.json
      /records/144/existing_route_snapshots/1/administration
      Historical; current review incomplete
      H51-4C9A977113C8E10BA028A3F8dosing.json
      /records/144/existing_route_snapshots/1/source_level
      Historical; current review incomplete
      H51-517234BE783343F50E74A1DBdosing.json
      /records/144/existing_route_snapshots/1/notes
      Historical; current review incomplete
      H51-9A926535811BEB8C377A06FFdosing.json
      /records/144/clinical_review/locally_normalized
      Historical; current review incomplete
      H51-913D431D736D8BDF084E911Adosing.json
      /records/144/clinical_review/reviewed
      Historical; current review incomplete
      H51-4F42E4891E3C1FE5CEBE4C17dosing.json
      /records/144/clinical_review/status
      Historical; current review incomplete
      H51-DA808AD3F2774F93BBCB1158dosing.json
      /records/144/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-D0A349D22030F41BEE623B07dosing.json
      /records/144/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-E41630322B435092FB2CF260dosing.json
      /records/144/clinical_release_verification/level
      Historical; current review incomplete
      H51-7A096CD1E1A0B0A2F775C3FCdosing.json
      /records/144/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-A434CB6D9F44327FFBF3C54Adosing.json
      /records/144/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-3878BFE4E31D6DD7B216BCEFdosing.json
      /records/144/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-EF7CDDFEC78263D35621B134dosing.json
      /records/144/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-4433D83D0C6B904D0CD7945Fdosing.json
      /records/144/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-DED4036BD00D67B7E08B1519dosing.json
      /records/144/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-EC0867137471AF75B580A3C5dosing.json
      /records/144/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-FFE40DA7ACCEF29A933FCA75dosing.json
      /records/144/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-7BEF4670A5BA751416B62179dosing.json
      /records/144/clinical_release_verification/note
      Historical; current review incomplete
      H51-F3AFC818F4CBCAFCEC9DC965dosing.json
      /records/144/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-26E6AC100ED2A6961BCCF45Ffirst-look-v5.1.json
      /records/144/id
      Historical; current review incomplete
      H51-45475949D160A3A677AC0546first-look-v5.1.json
      /records/144/generic_name
      Historical; current review incomplete
      H51-B2C14C19D45279BCEF85541Cfirst-look-v5.1.json
      /records/144/class
      Historical; current review incomplete
      H51-E3F2A4AD83263C4B990458AAfirst-look-v5.1.json
      /records/144/subclass
      Historical; current review incomplete
      H51-82DA5401F7AA77CEA893AE92first-look-v5.1.json
      /records/144/primary_uses/0
      Historical; current review incomplete
      H51-E3E5BA6CD5D1C1294779A97Ffirst-look-v5.1.json
      /records/144/mechanism
      Historical; current review incomplete
      H51-E2C55CBCF5BEEC328F97E12Ffirst-look-v5.1.json
      /records/144/mechanism_level
      Historical; current review incomplete
      H51-B67F357ECEEBD19BC7C05C25first-look-v5.1.json
      /records/144/basic_dosing_orientation
      Historical; current review incomplete
      H51-FD0ED9F6F2283DA7946596C9first-look-v5.1.json
      /records/144/administration_orientation
      Historical; current review incomplete
      H51-A2967BAC6408EF440E0A6E3Dfirst-look-v5.1.json
      /records/144/renal_and_population_orientation
      Historical; current review incomplete
      H51-867F27EECFAF82BF12F31553first-look-v5.1.json
      /records/144/key_safety_orientation/0
      Historical; current review incomplete
      H51-D3C5E76E6E4EFFA13C91CF2Bfirst-look-v5.1.json
      /records/144/key_safety_orientation/1
      Historical; current review incomplete
      H51-D224AC62DEC6DE5FD33ECDF1first-look-v5.1.json
      /records/144/coverage_path
      Historical; current review incomplete
      H51-0EE481ED4252D883AC88F24Ffirst-look-v5.1.json
      /records/144/coverage_path_label
      Historical; current review incomplete
      H51-4B541B7B69C799D2CA946F73first-look-v5.1.json
      /records/144/official_label_url
      Historical; current review incomplete
      H51-8F63BA84FBDE32ECB0631D29first-look-v5.1.json
      /records/144/legacy_title
      Historical; current review incomplete
      H51-B2E6797BFCEB1C05EB6502DBfirst-look-v5.1.json
      /records/144/review_note
      Historical; current review incomplete
      H51-EC652A9DC0D26BF3FD7FD036first-look-v5.1.json
      /records/144/search_text
      Historical; current review incomplete
      H51-B8037725267EF1A57E8B6B09first-look-v5.1.json
      /records/144/official_search_url
      Historical; current review incomplete
      H51-A03032387AFBCF73A9A3F211first-look-v5.1.json
      /records/144/official_access_mode
      Historical; current review incomplete
      H51-48DFD1AE65CB91A2ABBBD178first-look-v5.1.json
      /records/144/official_access_url
      Historical; current review incomplete
      H51-0FAF62B13AA89461C5B651F6first-look-v5.1.json
      /records/144/official_search_query
      Historical; current review incomplete
      H51-AF25259793A6E0C4DDE946FBfirst-look-v5.1.json
      /records/144/official_access_reason
      Historical; current review incomplete
      H51-B77CD7DB3F2AC769E5B27A80first-look-v5.1.json
      /records/144/label_snapshot_available
      Historical; current review incomplete
      H51-1A610B7C1D7643222D194A8Afirst-look-v5.1.json
      /records/144/label_snapshot_setid
      Historical; current review incomplete
      H51-BCA92F09C915AB9D3630D9B0preparation-assessments-v3.8.json
      /144/id
      Historical; current review incomplete
      H51-192DC07FE3906E1C14374578preparation-assessments-v3.8.json
      /144/name
      Historical; current review incomplete
      H51-6703F109D7376B6DB42F805Cpreparation-assessments-v3.8.json
      /144/brands
      Historical; current review incomplete
      H51-0D934D7E2AA5467F3EEB41A5preparation-assessments-v3.8.json
      /144/therapeutic_class
      Historical; current review incomplete
      H51-B64622538EB3B563ADF00582preparation-assessments-v3.8.json
      /144/review_version
      Historical; current review incomplete
      H51-02DA0C304B4E1B9DB67BFE53preparation-assessments-v3.8.json
      /144/review_date
      Historical; current review incomplete
      H51-3AEFFD95A13DD9436970D8D1preparation-assessments-v3.8.json
      /144/release_status
      Historical; current review incomplete
      H51-D62E299FD99A797C30672E3Dpreparation-assessments-v3.8.json
      /144/market_status/status
      Historical; current review incomplete
      H51-04DF267985B15CE68962A131preparation-assessments-v3.8.json
      /144/market_status/basis
      Historical; current review incomplete
      H51-1068DF5B4348CADC6B69C01Dpreparation-assessments-v3.8.json
      /144/ten_point_assessment/exact_formulation
      Historical; current review incomplete
      H51-33399054EC4543C783024B20preparation-assessments-v3.8.json
      /144/ten_point_assessment/reconstitution_concentration
      Historical; current review incomplete
      H51-CEF6F90AA8A2A3C55DC14C33preparation-assessments-v3.8.json
      /144/ten_point_assessment/maximum_or_recommended_final_concentration
      Historical; current review incomplete
      H51-53FBCDD0DEFFE4417C34D244preparation-assessments-v3.8.json
      /144/ten_point_assessment/appropriate_standardized_containers
      Historical; current review incomplete
      H51-98A424C8D3F4B2DB2901B82Cpreparation-assessments-v3.8.json
      /144/ten_point_assessment/adult_dosing_range
      Historical; current review incomplete
      H51-51EB610E4325194ABBC9984Epreparation-assessments-v3.8.json
      /144/ten_point_assessment/pediatric_dosing_range
      Historical; current review incomplete
      H51-02B342AF584844F26B8042B8preparation-assessments-v3.8.json
      /144/ten_point_assessment/neonatal_dosing_range
      Historical; current review incomplete
      H51-46E0169269B555E4D76F2D07preparation-assessments-v3.8.json
      /144/ten_point_assessment/infusion_time
      Historical; current review incomplete
      H51-6D01025B76B84E31A1A2A6BEpreparation-assessments-v3.8.json
      /144/ten_point_assessment/fluid_restriction_alternatives
      Historical; current review incomplete
      H51-5F5727DA1498FDB0C00C2311preparation-assessments-v3.8.json
      /144/ten_point_assessment/current_manufacturer_labeling/setid
      Historical; current review incomplete
      H51-8E2470767BE9BDBB3BFC736Apreparation-assessments-v3.8.json
      /144/ten_point_assessment/current_manufacturer_labeling/title
      Historical; current review incomplete
      H51-8CF13C00664D9AFDD1997D62preparation-assessments-v3.8.json
      /144/ten_point_assessment/current_manufacturer_labeling/published_date
      Historical; current review incomplete
      H51-AD881EE0AAC4A6A06EDA34F5preparation-assessments-v3.8.json
      /144/ten_point_assessment/current_manufacturer_labeling/manufacturer
      Historical; current review incomplete
      H51-BBF130FADE3305570512A0E3preparation-assessments-v3.8.json
      /144/ten_point_assessment/current_manufacturer_labeling/match_confidence
      Historical; current review incomplete
      H51-156B476CE3A772B7424DD1A7preparation-assessments-v3.8.json
      /144/ten_point_assessment/current_manufacturer_labeling/url
      Historical; current review incomplete
      H51-9A09CA7B23FF9260A680DC17preparation-assessments-v3.8.json
      /144/field_provenance/exact_formulation/primary
      Historical; current review incomplete
      H51-DE12C105DF1021A855A2D2FCpreparation-assessments-v3.8.json
      /144/field_provenance/reconstitution_concentration/primary
      Historical; current review incomplete
      H51-D40CD1EB72A2760F3FFFA3B4preparation-assessments-v3.8.json
      /144/field_provenance/maximum_or_recommended_final_concentration/primary
      Historical; current review incomplete
      H51-D5D7D3F73F40320CE64690D6preparation-assessments-v3.8.json
      /144/field_provenance/appropriate_standardized_containers/primary
      Historical; current review incomplete
      H51-AD5E30E35193FC3B9BDA517Bpreparation-assessments-v3.8.json
      /144/field_provenance/adult_dosing_range/primary
      Historical; current review incomplete
      H51-18FDE8895009589CB1E78021preparation-assessments-v3.8.json
      /144/field_provenance/pediatric_dosing_range/primary
      Historical; current review incomplete
      H51-E5305CA7A105772BFD686C4Bpreparation-assessments-v3.8.json
      /144/field_provenance/neonatal_dosing_range/primary
      Historical; current review incomplete
      H51-50EBD0CC6AF279C862C70E53preparation-assessments-v3.8.json
      /144/field_provenance/infusion_time/primary
      Historical; current review incomplete
      H51-6DCEA7FD1303D8C2B037C3A9preparation-assessments-v3.8.json
      /144/field_provenance/fluid_restriction_alternatives/primary
      Historical; current review incomplete
      H51-A093CEE43C023B27685E40ACpreparation-assessments-v3.8.json
      /144/field_provenance/current_manufacturer_labeling/primary
      Historical; current review incomplete
      H51-FEED401D04F749FFF126F307preparation-assessments-v3.8.json
      /144/population_applicability/adult/applicability
      Historical; current review incomplete
      H51-9E1D8EA051744A02D2C17C20preparation-assessments-v3.8.json
      /144/population_applicability/adult/guide_generation_allowed
      Historical; current review incomplete
      H51-6596683324DFAE11678CD41Fpreparation-assessments-v3.8.json
      /144/population_applicability/pediatric/applicability
      Historical; current review incomplete
      H51-6C6FDB761E7E5D6C782D6F0Bpreparation-assessments-v3.8.json
      /144/population_applicability/pediatric/guide_generation_allowed
      Historical; current review incomplete
      H51-F2E06C99FE9E9B11993CA919preparation-assessments-v3.8.json
      /144/population_applicability/neonatal/applicability
      Historical; current review incomplete
      H51-47B35A298120B9618EBD791Apreparation-assessments-v3.8.json
      /144/population_applicability/neonatal/guide_generation_allowed
      Historical; current review incomplete
      H51-A8E82FB3AC12638F172829DApreparation-assessments-v3.8.json
      /144/route_presence/structured_dilution
      Historical; current review incomplete
      H51-5E380301450D86A1E414BFC2preparation-assessments-v3.8.json
      /144/route_presence/iv_push
      Historical; current review incomplete
      H51-9715DDA077012B9A6F087D2Dpreparation-assessments-v3.8.json
      /144/route_presence/continuous_infusion
      Historical; current review incomplete
      H51-B7F1B8499812B41A9D6B8221preparation-assessments-v3.8.json
      /144/route_presence/pediatric_source
      Historical; current review incomplete
      H51-294118602529701A8A1E7F9Bpreparation-assessments-v3.8.json
      /144/route_presence/neonatal_source
      Historical; current review incomplete
      H51-0BF915FF33D5C7C72B6E9082preparation-assessments-v3.8.json
      /144/legacy_reference/status
      Historical; current review incomplete
      H51-882936034BBE320BBAEBBBA1preparation-assessments-v3.8.json
      /144/label_resolution/status
      Historical; current review incomplete
      H51-94C078ECD8B054E78F80F558preparation-assessments-v3.8.json
      /144/label_resolution/existing_setids/0
      Historical; current review incomplete
      H51-7724139FDA90BBE662356A94preparation-assessments-v3.8.json
      /144/concentration_values_detected/0
      Historical; current review incomplete
      H51-8C7E2EF8EEFBBD4AF59AA99Fpreparation-assessments-v3.8.json
      /144/concentration_values_detected/0/low
      Historical; current review incomplete
      H51-4AC9C6B9D01D60B92ACEEB68preparation-assessments-v3.8.json
      /144/concentration_values_detected/0/high
      Historical; current review incomplete
      H51-E513254F3EFB8999B17F95A8preparation-assessments-v3.8.json
      /144/concentration_values_detected/0/unit
      Historical; current review incomplete
      H51-60508C0EBF44AB06EEEBEE3Cpreparation-assessments-v3.8.json
      /144/concentration_values_detected/0/text
      Historical; current review incomplete
      H51-4B05123F41A0E2A1FAED3EE1preparation-assessments-v3.8.json
      /144/source_files/0
      Historical; current review incomplete
      H51-58A0A1364EC9425C320A2CDEpreparation-assessments-v3.8.json
      /144/source_files/1
      Historical; current review incomplete
      H51-BB24117F01AB73A38981CCE4preparation-assessments-v3.8.json
      /144/source_files/2
      Historical; current review incomplete
      H51-B558E50D9F565EBE80806400preparation-assessments-v3.8.json
      /144/clinical_release_note
      Historical; current review incomplete